Chemspec-API formed as joint venture of Shanghai Chemspec Corp. and API Inc., providing clients with a US manufacturer of APIs and pharmaceutical intermediates with access to extensive resources at Shanghai Chemspec.

Picture1

Chemspec-API today announced its formation as a joint venture of Shanghai Chemspec Corp. and API Inc.  The agreement between the two companies means that API Inc.’s Fairfield facility will operate as Chemspec-API, providing process research and development, cGMP production and CMC services.  In addition to this, clients will now have seamless access to resources at Shanghai Chemspec with project management at Fairfield.

Continue reading